NPM1, RKIP/PEBP1 and GRP78 expressions were significantly distinct in GBMs and oligodendrogliomas compared to AST II and NN (p < 0.0001, blocked t test), corroborating previous data of our group [4–6]. The gene discussed is HSPA5; the disease is oligodendroglioma.